Navigation Links
WMIS Supports Experts, Commits to Resolve Beta Amyloid Issues with CMS
Date:2/7/2013

Washington DC (PRWEB) February 07, 2013

On January 30th, 2013 CMS (Centers for Medicare & Medicaid Services) held the MEDCAC (Medicare Evidence Development & Coverage Advisory Committee) meeting to review the available evidence and hear public testimony on the use of beta amyloid PET imaging for the management of dementia and neurodegenerative disease. At the conclusion of the presentations and discussion, the panel voted ‘low to intermediate’ confidence in evidence supporting the PET imaging of brain beta amyloid to change health outcomes (improved, equivalent or worsened) in patients who display early symptoms or signs of cognitive dysfunction.
Based upon the scientific evidence acquired over the years, WMIS supports the position that PET Imaging does change the health outcomes. This position is similar to the testimony of several experts who presented during the meeting. “We stay firm in our belief that PET imaging can truly help improve health outcomes in patients and we support the testimony of the medical experts. We are committed to work with CMS to resolve any outstanding issues about beta amyloid imaging.” said Kim Pierce, Executive Director of WMIS.

WMIS is the molecular imaging sector’s largest source of information and data on reimbursement since it manages the NOPR. The National Oncologic PET Registry (NOPR) is a collaboration of the American College of Radiology Imaging Network (ACRIN), the American College of Radiology (ACR), and the World Molecular Imaging Society (WMIS), to ensure access to Medicare reimbursement for certain types of positron emission tomography (PET) scans.

The testimony of medical experts clearly demonstrated that significant evidence already exists. “It is important to recognize that the panel is concerned about insufficient evidence and is not questioning the fundamental premise of the diagnostic test. We invite CMS to work with the industry and molecular imaging societies to receive further clarification. We firmly believe that the opinions of the well-recognized experts in the field should be given priority to determine the future of this FDA approved powerful innovation.” Kim Pierce added.

About WMIS
WMIS is an academic and professional society for Molecular Imaging. From leading projects such as PET awareness campaigns and registry management on the clinical side to developing powerful preclinical models and training programs, WMIS is active across the entire spectrum of Molecular Imaging. WMIS is the world's most innovative and leading society in molecular imaging and molecular medicine. With the rise of the molecular imaging industry and the associated research, WMIS is the only organization that is connecting all the dots in the industry and is working to bring all stakeholders together by Smashing the Silos and Leading Innovation Convergence in molecular medicine through imaging; both for practitioners and researchers, who are defining the future of molecular imaging, WMIS enhances the potential and applications of innovation. http://www.wmis.org

Read the full story at http://www.prweb.com/releases/2013/2/prweb10402159.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
2. Discovery in Nature elucidates immune cells in skin and supports novel vaccine approach
3. MDA Supports Development of Dissociative Glucocorticoid for DMD
4. InVigor® Canola Supports the Michigan-Whitman Fire Department with More for Everyone Award
5. InVigor® Canola Supports Cando Youth Hockey with More for Everyone Award
6. InVigor® Canola Supports Langdon Day Care Center with More for Everyone Award
7. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
8. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
9. CoreLab Partners, Medical Image Assessment Experts, Announces Its Entry Into the Early Alzheimers Imaging Market Space
10. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
11. Cellectricon Launches Dynaflow® Resolve System Enabling Novel Ion Channel Assays
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... Calif. , Feb. 11, 2016  Dovetail Genomics™ ... to its beta program for a planned metagenomic genome ... present the company,s metagenomic genome assembly method in a ... in Genome Biology & Technology conference in ... of these highly complex datasets is difficult. Using its ...
(Date:2/11/2016)... ... February 11, 2016 , ... Global Stem ... clinic in Quito, Ecuador. The new facility will provide advanced protocols and state-of-the-art ... around the world. , The new GSCG clinic is headed by four ...
(Date:2/10/2016)... is introducing a hybrid membership model which will provide ... joining or renewing through an organizational purchasing model. For ... employee in any size association or AMC office can ... benefits.   John H. Graham, IV , ... organizations of any size and their employees to gain ...
(Date:2/10/2016)... ... 2016 , ... Benchmark Research, a fully-integrated network of ... principal investigators (PI) to the roles of Chief Medical Officer, Clinical Research and ... Chu, a Benchmark Research PI in the Austin office, will assume the role ...
Breaking Biology Technology:
(Date:1/13/2016)... 2016 --> ... market report titled - Biometric Sensors Market - Global Industry ... 2023. According to the report, the global biometric sensors market was valued ... reach US$1,625.8 mn by 2023, expanding at a CAGR ... volume, the biometric sensors market is expected to reach ...
(Date:1/11/2016)... Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... today announced that its ClearPad ® TouchView ™ ... won two separate categories in the 8 th ... Best Technology Breakthrough. The Synaptics ® TDDI solution ... supply chain, thinner devices, brighter displays and borderless designs. ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016   ... diagnostic products, today announced the closing of a $9 million ... Proceeds from the financing will be used to accelerate the ... for detecting early-stage pressure ulcers. United ... receiving CE Mark approval. The device,s introduction has been met ...
Breaking Biology News(10 mins):